Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease

International Journal of Cardiology

Volumn 161, Issue 3, 2012, Pages 156-159

  Marcun, Robert ^a   Sustic, Alan ^b   Brguljan, Pika Mesko ^a   Kadivec, Sasa ^a   Farkas, Jerneja ^c   Kosnik, Mitja ^a   Coats, Andrew J Stewart ^d   Anker, Stefan D ^e,f   Lainscak, Mitja ^a,e  

^a UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^b KBC RIJEKA   (Croatia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

^d NORWICH RESEARCH PARK   (United Kingdom)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Biomarkers; Chronic obstructive pulmonary disease; Death; Hospitalisation; NT proBNP; Troponin

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; TROPONIN T;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIASTOLIC DYSFUNCTION; DISEASE CLASSIFICATION; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VITAL CAPACITY;

EID: 84869505623     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.05.044     Document Type: Article

References (32)

1. K.F. Rabe, S. Hurd, and A. Anzueto Global strategy for the diagnosis, management and prevention of COPD - 2006 update Am J Respir Crit Care Med 176 2007 532 555
2. A.D. Lopez, K. Shibuya, and C. Rao Chronic obstructive pulmonary disease: current burden and future projections Eur Respir J 27 2006 397 412
3. P.J. Barnes, and B.R. Celli Systemic manifestations and comorbidities of COPD Eur Respir J 33 2009 1165 1185
4. W. Doehner, S. von Haehling, S.D. Anker, and M. Lainscak Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review Wien Klin Wochenschr 121 2009 293 296
5. P.H. Brekke, T. Omland, S.H. Holmedal, P. Smith, and V. Soyseth Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation Eur Respir J 31 2008 563 570
6. O. Fruchter, and M. Yigla Cardiac troponin-I predicts long-term mortality in chronic obstructive pulmonary disease COPD 6 2009 155 161
7. C.S. Martins, M.J.O. Rodrigues, V.P. Miranda, and J.P.L. Nunes Prognostic value of cardiac troponin I in patients with COPD acute exacerbation Neth J Med 67 2009 341 349
8. A.D. Hoseth, A. Neukamm, B.D. Karlsson, T. Omland, P.H. Brekke, and V. Soyseth Elevated high-sensitivity cardiac troponin T is associated with increased mortality rafter aute exacerbation gof cronic obstructive pulmonary disease Thorax 66 2011 775 781
9. D. Stolz, T. Breidthardt, and M. Christ-Crain Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD Chest 133 2008 1088 1094
10. A.M. Medina, M.S. Marteles, and E.B. Saiz Prognostic utility of NT-proBNP in acute exacerbation of chronic pulmonary disease Eur J Intern Med 22 2011 167 171
11. M. Bernasconi, M. Tamm, and R. Bingisser Midregional proatrial natriuretic peptide predicts survival in exacerbations of COPD Chest 140 2011 91 99
12. C.L. Chang, S.C. Robinson, and G.D. Mills Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD Thorax 66 2011 764 768
13. J. Farkas, S. Kadivec, M. Kosnik, and M. Lainscak Effectiveness of discharge-coordinator intervention in patients with chronic obstructive pulmonary disease: study protocol of a randomized controlled clinical trial Respir Med 105 Suppl. 1 2011 S26 S30
14. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2
15. W.J. Paulus, C. Tschöpe, and J.E. Sandersun How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2007 2539 2550
16. P. Faggiano, R. Valle, and N. Aspromonte How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification Int J Cardiol 140 2010 88 94
17. A. Maisel, C. Mueller, and K. Adams Jr. State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 2008 824 839
18. M. Panthegini, W. Gerhardt, F.S. Apple, F. Dati, J. Ravkilde, and A.H. Wu Quality specifications for cardiac troponin assays Clin Chem Lab Med 39 2001 175 179
19. M. Vasquez, K. Jockers, M. Christ-Crain, W. Zimmerli, B. Müller, and P. Schuetz MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study Int J Cardiol 156 2012 16 23
20. A. Lacoma, C. Prat, and F. Andreo Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease Clin Chim Acta 412 2011 470 475
21. H.H. Leuchte, R.A. Baumgartner, and M. El Nounou Brain natriuretic peptide is a prognostic parameter in chronic lung disease Am J Respir Crit Care Med 173 2006 744 750
22. E. Odigie-Okon, B. Jordan, and S. Dijeh Cardiac injury in patients with COPD presenting with dispnea: a pilot study Int J Chron Obstruct Pulmon Dis 5 2010 395 399
23. C. Baillard, M. Boussarsar, and J.P. Fosse Cardiac troponin I patients with severe exacerbation of chronic obstructive pulmonary disease Intensive Care Med 29 2003 584 589
24. F. Abroug, L. Ouanes-Besbes, and N. Nciri Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease Am J Respir Crit Care Med 174 2006 990 996
25. G.B.J. Mancini, M. Etminan, B. Zhang, L.E. Levesque, J.M. FitzGerald, and J.M. Brophy Reduction of morbidity and mortality by statins, angitensin-converting enzyme inhibitors, and angiotensin receptor blockers in patient with chronic obstructive pulmonary disease J Am Coll Cardiol 12 2006 2554 2560
26. M. Lainscak, L. Majc Hodoscek, and H.D. Düngen The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure Wien Klin Wochenschr 121 2009 309 313
27. L.M. Fabbri, B. Beghe, and A. Agusti Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guideliens Thorax 66 2011 745 747
28. A.R.C. Patel, G.C. Donaldson, A.J. Mackay, J.A. Wedzicha, and J.R. Hurst The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD Chest 141 2012 851 857
29. J. Mascarenhas, A. Azevedo, and P. Bettencourt Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality Curr Opin Pulm Med 16 2010 106 111
30. C. Ceconi, and R. Ferrari One heart, two lungs together forever Am J Respir Crit Care Med 174 2006 962 963
31. S. Suskovic, M. Kosnik, and M. Lainscak Heart failure and chronic obstructive pulmonary disease: two for tea or tea for two? World J Cardiol 2 2010 305 307
32. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989